Back to results
US 2019/0314314 A1Published application
Composition and method for dual targeting in treatment of neuroendocrine tumors
AssigneeNanopharmaceuticals LLC
InventorsShaker Mousa, Mehdi Rajabi, Ozlem O. Karakus
Life of this patent
Estimating the term…
Abstract
Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone αvβ3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
Claims22
A compound comprising:
- N-benzyl guanidine;
- and
- a thyrointegrin αvβ3 receptor antagonist;
- wherein the N-benzyl guanidine and the thyrointegrin αvβ3 receptor antagonist are connected by a linker.
1 more element
A composition comprising:
- a compound of a general formula:
- or a salt thereof;
- wherein R1, R2, R3, and R4 are each independently selected from the group consisting of hydrogen, iodine, fluorine, bromine, a methoxy group, a nitro group, an amine group, and a nitrile group;
- wherein R5, R6, R7, and R8 are each independently selected from the group consisting of hydrogen, iodine, and an alkane group;
- and
- n1≥0;
- n2≥1;
- and
5 more elements
A composition for dual targeting of tumor cells, comprising:
- a norepinephrine transporter target;
- and
- a thyrointegrin αvβ3 receptor antagonist;
- wherein the norepinephrine transporter target and the αvβ3 thyrointegrin receptor antagonist are connected by a linker;
- further wherein the composition is configured to dual target tumor cells via a) the norepinephrine transporter and b) binding with the integrin αvβ3 receptor.
2 more elements
Dependencies are inferred from the claim text.